Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
1 Feb 2021	Submitted	Original manuscript
2 Feb 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
2 Feb 2021	Editorially accepted
11 Feb 2021	Article published	10.1186/s13063-021-05095-x

Back to article page